Omentin as an Independent Predictor of Metabolic Syndrome and Obesity Among Adolescents in Northeast China

References

• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–1428. doi:10.1016/S0140-6736(05)66378-7
   PubMed Web of Science ®Google Scholar
• Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(12):1131–1141. doi:10.1056/NEJMra1011035
   PubMed Web of Science ®Google Scholar
• Hudish LI, Reusch JE, Sussel L. β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019;129(10):4001–4008. doi:10.1172/JCI129188
   PubMed Web of Science ®Google Scholar
• Magge SN, Goodman E, Armstrong SC. The metabolic syndrome in children and adolescents: shifting the focus to cardiometabolic risk factor clustering. Pediatrics. 2017;140(2). doi:10.1542/peds.2017-1603
   PubMed Web of Science ®Google Scholar
• Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786. doi:10.3390/ijms23020786
   PubMed Web of Science ®Google Scholar
• Walker SE, Gurka MJ, Oliver MN, Johns DW, DeBoer MD. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis. 2012;22(2):141–148. doi:10.1016/j.numecd.2010.05.006
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care. 2008;31(3):587–589. doi:10.2337/dc07-1030
   Web of Science ®Google Scholar
• Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16:296. doi:10.1186/s12889-016-2870-y
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang Y, Zhang F, Wu C, Qin F, Yuan J. Prevalence and associated factors of metabolic syndrome in Chinese middle-aged and elderly population: a national cross-sectional study. Aging Male. 2021;24(1):148–159. doi:10.1080/13685538.2021.1998432
   PubMed Web of Science ®Google Scholar
• Alshammary AF, Alharbi KK, Alshehri NJ, Vennu V, Ali Khan I. Metabolic syndrome and coronary artery disease risk: a meta-analysis of observational studies. Int J Environ Res Public Health. 2021;18(4):1773. doi:10.3390/ijerph18041773
   PubMed Web of Science ®Google Scholar
• DeBoer MD. Assessing and managing the metabolic syndrome in children and adolescents. Nutrients. 2019;11(8):1788. doi:10.3390/nu11081788
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang B, Hao C, et al. Omentin-a novel adipokine in respiratory diseases. Int J Mol Sci. 2017;19(1):73. doi:10.3390/ijms19010073
   Web of Science ®Google Scholar
• Herder C, Kannenberg JM, Niersmann C, et al. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol. 2017;177(4):277–286. doi:10.1530/EJE-17-0100
   PubMed Web of Science ®Google Scholar
• Tsiotra PC, Halvatsiotis P, Patsouras K, et al. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus. Peptides. 2018;101:157–166. doi:10.1016/j.peptides.2018.01.005
   PubMed Web of Science ®Google Scholar
• Franz M, Polterauer M, Springer S, et al. Maternal and neonatal omentin-1 levels in gestational diabetes. Arch Gynecol Obstet. 2018;297(4):885–889. doi:10.1007/s00404-018-4652-5
   Web of Science ®Google Scholar
• Orlik B, Madej P, Owczarek A, Skałba P, Chudek J, Olszanecka-Glinianowicz M. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol. 2014;81(4):529–535. doi:10.1111/cen.12381
   Web of Science ®Google Scholar
• Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract. 2011;93(1):21–25. doi:10.1016/j.diabres.2011.03.001
   PubMed Web of Science ®Google Scholar
• Zhao A, Xiao H, Zhu Y, et al. Omentin-1: a newly discovered warrior against metabolic related diseases. Expert Opin Ther Targets. 2022;26(3):275–289. doi:10.1080/14728222.2022.2037556
   PubMed Web of Science ®Google Scholar
• Alshammary AF, Khan IA. Screening of obese offspring of first-cousin consanguineous subjects for the angiotensin-converting enzyme gene with a 287-bp Alu sequence. J Obes Metabol Syndr. 2021;30(1):63–71. doi:10.7570/jomes20086
   Web of Science ®Google Scholar
• Alharbi KK, Al-Sheikh YA, Alsaadi MM, et al. Screening for obesity in the offspring of first-cousin consanguineous couples: a Phase-I study in Saudi Arabia. Saudi J Biol Sci. 2020;27(1):242–246. doi:10.1016/j.sjbs.2019.09.001
   Web of Science ®Google Scholar
• Zengi S, Zengi O, Kirankaya A, Kucuk SH, Kutanis EE, Yigit O. Serum omentin-1 levels in obese children. J Pediatr Endocrinol Metab. 2019;32(3):247–251. doi:10.1515/jpem-2018-0231
   PubMed Web of Science ®Google Scholar
• Gupta N, Goel K, Shah P, Misra A. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev. 2012;33(1):48–70. doi:10.1210/er.2010-0028
   PubMed Web of Science ®Google Scholar
• Pacheco LS, Blanco E, Burrows R, Reyes M, Lozoff B, Gahagan S. Early onset obesity and risk of metabolic syndrome among Chilean adolescents. Prev Chronic Dis. 2017;14:E93. doi:10.5888/pcd14.170132
   Web of Science ®Google Scholar
• Christian Flemming GM, Bussler S, Körner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab. 2020;33(7):821–833. doi:10.1515/jpem-2019-0552
   Web of Science ®Google Scholar
• Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - An IDF consensus report. Pediatr Diabetes. 2007;8(5):299–306. doi:10.1111/j.1399-5448.2007.00271.x
   PubMed Web of Science ®Google Scholar
• Ma GS, Ji CY, Ma J, et al. 中国7～18岁学龄儿童青少年腰围界值点研究 [Waist circumference reference values for screening cardiovascular risk factors in Chinese children and adolescents aged 7–18 years]. Zhonghua liu xing bing xue za zhi. 2010;31(6):609–615. Chinese.
   Google Scholar
• Group of China Obesity Task Force. 中国学龄儿童青少年超重、肥胖筛查体重指数值分类标准 [Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents]. Zhonghua liu xing bing xue za zhi. 2004;25(2):97–102. Chinese.
   Google Scholar
• Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290(6):E1253–1261. doi:10.1152/ajpendo.00572.2004
   PubMed Web of Science ®Google Scholar
• Reinehr T, Roth CL. Inflammation markers in type 2 diabetes and the metabolic syndrome in the pediatric population. Curr Diab Rep. 2018;18(12):131. doi:10.1007/s11892-018-1110-5
   PubMed Web of Science ®Google Scholar
• Watanabe T, Watanabe-Kominato K, Takahashi Y, Kojima M, Watanabe R. Adipose tissue-derived omentin-1 function and regulation. Compr Physiol. 2017;7(3):765–781.
   PubMed Web of Science ®Google Scholar
• Herder C, Ouwens DM, Carstensen M, et al. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol. 2015;172(4):423–432. doi:10.1530/EJE-14-0879
   PubMed Web of Science ®Google Scholar
• Escoté X, Gómez-Zorita S, López-Yoldi M, et al. Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development. Int J Mol Sci. 2017;18(8):1770. doi:10.3390/ijms18081770
   PubMed Web of Science ®Google Scholar
• Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013;98(3):E514–517. doi:10.1210/jc.2012-3673
   PubMed Web of Science ®Google Scholar
• Shibata R, Ouchi N, Takahashi R, et al. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr. 2012;4(1):37. doi:10.1186/1758-5996-4-37
   PubMed Web of Science ®Google Scholar
• Vu A, Sidhom MS, Bredbeck BC, Kosmiski LA, Aquilante CL. Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetol Metab Syndr. 2014;6(1):4. doi:10.1186/1758-5996-6-4
   Web of Science ®Google Scholar
• Auguet T, Quintero Y, Riesco D, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 2011;12:60. doi:10.1186/1471-2350-12-60
   PubMed Web of Science ®Google Scholar
• Cetin Sanlialp S, Nar G, Nar R. Relationship between circulating serum omentin-1 levels and nascent metabolic syndrome in patients with hypertension. J Investig Med. 2022;70(3):780–785. doi:10.1136/jim-2021-002071
   Web of Science ®Google Scholar
• Dağdelen D, Karadag AS, Kasapoğlu E, Wang JV, Erman H. Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis. Dermatol Ther. 2020;33(6):e14378. doi:10.1111/dth.14378
   Web of Science ®Google Scholar
• Madsen SM, Thorup AC, Bjerre M, Jeppesen PB. Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome? Arch Physiol Biochem. 2015;121(4):129–138. doi:10.3109/13813455.2015.1082600
   PubMed Web of Science ®Google Scholar
• Borowski A, Sieminska L. Serum omentin levels in patients with prostate cancer and associations with sex steroids and metabolic syndrome. J Clin Med. 2020;9(4):1179. doi:10.3390/jcm9041179
   Web of Science ®Google Scholar
• Buyukinan M, Atar M, Can U, Pirgon O, Guzelant A, Deniz I. The association between serum vaspin and omentin-1 levels in obese children with metabolic syndrome. Metab Syndr Relat Disord. 2018;16(2):76–81. doi:10.1089/met.2017.0133
   Web of Science ®Google Scholar
• Zhang M, Tan X, Yin C, Wang L, Tie Y, Xiao Y. Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome. Acta Paediatr. 2017;106(11):1851–1856. doi:10.1111/apa.14026
   Web of Science ®Google Scholar
• Moreno-Navarrete JM, Catalán V, Ortega F, et al. Circulating omentin concentration increases after weight loss. Nutr Metab. 2010;7:27. doi:10.1186/1743-7075-7-27
   Google Scholar
• de Souza Batista CM, Yang RZ, Lee MJ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56(6):1655–1661. doi:10.2337/db06-1506
   PubMed Web of Science ®Google Scholar
• Prats-Puig A, Bassols J, Bargalló E, et al. Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children. Obesity. 2011;19(9):1905–1907. doi:10.1038/oby.2011.198
   PubMed Web of Science ®Google Scholar
• Siegrist M, Heitkamp M, Braun I, et al. Changes of omentin-1 and chemerin during 4 weeks of lifestyle intervention and 1 year follow-up in children with obesity. Clin Nutr. 2021;40(11):5648–5654. doi:10.1016/j.clnu.2021.09.042
   PubMed Web of Science ®Google Scholar
• Rothermel J, Lass N, Barth A, Reinehr T. Link between omentin-1, obesity and insulin resistance in children: findings from a longitudinal intervention study. Pediatr Obes. 2020;15(5):e12605. doi:10.1111/ijpo.12605
   PubMed Web of Science ®Google Scholar
• Tan YL, Zheng XL, Tang CK. The protective functions of omentin in cardiovascular diseases. Clin Chim Acta. 2015;448:98–106. doi:10.1016/j.cca.2015.05.019
   PubMed Web of Science ®Google Scholar
• Shang FJ, Wang JP, Liu XT, et al. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers. 2011;16(8):657–662. doi:10.3109/1354750X.2011.622789
   PubMed Web of Science ®Google Scholar
• Stejskal D, Vaclavik J, Smekal A, Svobodova G, Richterova R, Svestak M. Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication. Biomed Pap Med Fac Univ. 2016;160(2):219–221. doi:10.5507/bp.2016.019
   PubMed Web of Science ®Google Scholar
• Zhou JY, Chan L, Zhou SW. Omentin: linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol. 2014;12(1):136–143. doi:10.2174/1570161112999140217095038
   PubMed Web of Science ®Google Scholar
• Askin L, Duman H, Ozyildiz A, Tanriverdi O, Turkmen S. Association between omentin-1 and coronary artery disease: pathogenesis and clinical research. Curr Cardiol Rev. 2020;16(3):198–201. doi:10.2174/1573403X16666200511085304
   PubMed Web of Science ®Google Scholar